BlackThorn Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery and development of targeted medicines for the treatment of central nervous system (CNS) disorders. With pathfinder™, our computational psychiatry platform, our approach is based on generating a quantitative, brain-based understanding of neurobehavioral disorders. These data-driven insights are applied to create treatments targeted to biologically-based subtypes of patients to increase the precision of therapeutic intervention. Our clinical pipeline is designed to restore balance to dysregulated brain circuits and empower individuals with CNS disorders to live better lives. BlackThorn is headquartered in San Francisco, California. For more information, please visit blackthornrx.com.
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $130M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | Mercury Fu... | mercuryfun... |
| - | ARCH Ventu... | archventur... |
| - | Altitude L... | altitudels... |
| - | GV | gv.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 20.06.2019 | Series B | $76M | - |
| 05.01.2017 | Series A | $14M | - |
| 20.10.2016 | Series A | $40M | - |
Mentions in press and media 16
| Date | Title | Description |
| 21.04.2022 | Embracing an ML-first mindset helps startups accelerate time-to-market and build long-term competitiveness | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Of the many fascinating insights I get from worki... |
| 26.11.2019 | Mental health companies that have raised funding this year | Big companies like Quartet and Calm raised funding as did seed-stage companies like UpLift Health For the past couple of years, Vator, along with HP and UCSF Health Hub, has been holding salons about different aspects of the healthcare spac... |
| 20.06.2019 | BlackThorn Therapeutics Secures $76 Million To Develop AI-Based Personalized Medicine For Mental Health | Clinical-stage neurobehavioral health company BlackThorn Therapeutics announced it raised $76 million in Series B funding BlackThorn Therapeutics is a clinical-stage neurobehavioral health company that is pioneering next-generation artifici... |
| 14.06.2019 | BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Health | - |
| 14.06.2019 | Why Facebook’s Secretive Cryptocurrency Project Matters: Term Sheet | INVESTING IN LIBRA Well, here’s a financing you don’t see every day. Paid Content Securing the enterprise without boundaries From ExtraHop Although the project is still largely under wraps, Facebook has been recruiting high-profile backers ... |
| 13.06.2019 | BlackThorn Therapeutics Completes $76M Series B Funding | BlackThorn Therapeutics, a San Francisco, California-based clinical-stage, neurobehavioral health company pioneering next-generation artificial intelligence (AI) technologies to advance targeted therapeutics, closed a $76m Series B financin... |
| 13.06.2019 | Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders | There are numerous challenges to finding effective treatments for mental disorders. However, BlackThorn Therapeutics, a neurobehavioral health company using machine learning to create personalized medicine for mental health, is betting its ... |
| 13.06.2019 | BlackThorn bags $76M to push targeted treatments for brain disorders | BlackThorn Therapeutics raised $76 million to push at least one of its targeted treatments for neurobehavioral disorders into phase 2 trials and to keep working on the machine learning-based technology that underlies its clinical pipeline. ... |
| 13.06.2019 | BlackThorn bags $76M to push targeted treatments for brain disorders | BlackThorn Therapeutics raised $76 million to push at least one of its targeted treatments for neurobehavioral disorders into phase 2 trials and to keep working on the machine learning-based technology that underlies its clinical pipeline. ... |
| 13.06.2019 | BlackThorn Therapeutics Lands $76M | SAN FRANCISCO, CA, BlackThorn Therapeutics today announced the close of its $76 million Series B financing. >> Click here for more funding data on BlackThorn Therapeutics >> To export BlackThorn Therapeutics funding data to ... |
Show more